Code Biotherapeutics
PrivateLast Round
Series A
Jun 7, 2022
Total Funding Raised
$85M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Code Biotherapeutics is a biotechnology company that develops non-viral gene therapies for serious and life-threatening genetic disorders using its proprietary 3DNA delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Code Biotherapeutics Comparables
Compare Code Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BreezeBio | 87% | |
| Resilience | 81% | |
| Mirai Bio | 78% | |
Code Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 7, 2022 | ||||
| Seed | Apr 20, 2021 |
Code Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Series A |
| CureDuchenne Ventures | Seed, Series A |
| New Enterprise Associates (NEA) | Series A, Seed |
| Hatteras Venture Partners | Series A |
| 4BIO Capital | Series A, Seed |
| UCB Ventures | Series A |
| Northpond Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 45% MoM, reaching 1.4K.
- Jun 7, 2022
$75M round led by Northpond Ventures.
Code Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Code Biotherapeutics's valuation, stock price, and market status.